https://www.sciencedaily.com/news/health_medicine/caregiving/ Make informed caregiving and home health care choices for your loved ones. Read the latest research for caregivers on caregiving. en-us Mon, 20 Apr 2026 02:47:14 EDT Mon, 20 Apr 2026 02:47:14 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/caregiving/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260416071947.htm A rogue set of “zombie” immune cells may be driving aging and fatty liver disease by flooding tissues with inflammation. Researchers found these cells accumulate with age and high cholesterol—and can make up most of the liver’s immune cells in older mice. When scientists removed them, liver damage was dramatically reversed, even without diet changes. Thu, 16 Apr 2026 07:59:44 EDT https://www.sciencedaily.com/releases/2026/04/260416071947.htm https://www.sciencedaily.com/releases/2026/04/260414075648.htm A lifetime of mental stimulation—like reading, writing, and learning new skills—may help protect the brain as we age. People with the highest levels of cognitive enrichment had a much lower risk of Alzheimer’s and experienced symptoms years later than those with the lowest levels. Wed, 15 Apr 2026 04:09:05 EDT https://www.sciencedaily.com/releases/2026/04/260414075648.htm https://www.sciencedaily.com/releases/2026/04/260414075646.htm A major new study reveals that treating gout may do far more than ease painful joint flare-ups—it could also protect the heart. Researchers found that patients who took common gout medications like allopurinol and successfully lowered their blood urate levels had a significantly reduced risk of heart attacks, strokes, and cardiovascular death over five years. Tue, 14 Apr 2026 23:11:38 EDT https://www.sciencedaily.com/releases/2026/04/260414075646.htm https://www.sciencedaily.com/releases/2026/04/260413043141.htm Scientists have developed a new way to fight gum disease without wiping out the mouth’s helpful bacteria—a major shift from traditional treatments. Instead of killing everything, this targeted approach blocks only the harmful microbes that drive periodontitis, allowing beneficial bacteria to thrive and restore balance naturally. Mon, 13 Apr 2026 10:02:46 EDT https://www.sciencedaily.com/releases/2026/04/260413043141.htm https://www.sciencedaily.com/releases/2026/04/260411043048.htm Losing your sense of smell might signal Alzheimer’s far earlier than expected. Scientists found that immune cells in the brain actively destroy smell-related nerve fibers after detecting abnormal signals on their surfaces. This damage begins in early stages of the disease, well before cognitive decline. The discovery could help identify at-risk patients sooner and improve treatment timing. Sat, 11 Apr 2026 08:13:19 EDT https://www.sciencedaily.com/releases/2026/04/260411043048.htm https://www.sciencedaily.com/releases/2026/04/260409101111.htm Alzheimer’s isn’t just one problem—it’s a tangled mix of biology, aging, and overall health. That’s why drugs targeting a single factor have fallen short, even as new treatments show modest benefits. Scientists are now pushing toward multi-pronged strategies, from gene editing to brain-cell rejuvenation and gut health interventions. The goal: stop treating Alzheimer’s as one disease and start tackling it as a complex system. Fri, 10 Apr 2026 10:12:15 EDT https://www.sciencedaily.com/releases/2026/04/260409101111.htm https://www.sciencedaily.com/releases/2026/04/260408225933.htm Scientists have uncovered a surprising new player in Alzheimer’s disease: a protein called CSE that helps produce tiny amounts of hydrogen sulfide gas in the brain. In experiments with genetically engineered mice, removing this protein led to memory loss, brain damage, and other hallmarks of Alzheimer’s, including weakened blood-brain barriers and reduced formation of new neurons. The findings suggest that this “rotten egg” gas, when carefully regulated, may actually protect brain cells and support memory. Wed, 08 Apr 2026 22:59:33 EDT https://www.sciencedaily.com/releases/2026/04/260408225933.htm https://www.sciencedaily.com/releases/2026/04/260406192922.htm Scientists at Oregon State University have captured something researchers have long struggled to see: the real-time chemical interactions that help drive Alzheimer’s disease. By watching how metal ions—especially copper—trigger harmful protein clumping in the brain, the team uncovered a clearer picture of how the disease develops at a molecular level. Tue, 07 Apr 2026 07:37:31 EDT https://www.sciencedaily.com/releases/2026/04/260406192922.htm https://www.sciencedaily.com/releases/2026/04/260406192913.htm A single week of intensive meditation and mind-body practices led to measurable changes across the brain and body. Researchers observed improved brain efficiency, boosted immune signaling, and increased natural pain relief chemicals in participants’ blood. The effects even promoted neuron growth and stronger brain connectivity. Surprisingly, the experience mirrored psychedelic-like brain states—without any drugs involved. Tue, 07 Apr 2026 03:56:04 EDT https://www.sciencedaily.com/releases/2026/04/260406192913.htm https://www.sciencedaily.com/releases/2026/04/260401071931.htm A surprising new study suggests that genetics may change how diet affects brain health—especially when it comes to Alzheimer’s risk. Researchers found that older adults carrying high-risk APOE gene variants didn’t show the expected cognitive decline if they ate relatively high amounts of meat. In fact, those with these genes who consumed the most meat had slower cognitive decline and lower dementia risk, challenging conventional dietary advice. Thu, 02 Apr 2026 13:54:07 EDT https://www.sciencedaily.com/releases/2026/04/260401071931.htm https://www.sciencedaily.com/releases/2026/03/260330084511.htm A major analysis of nearly 10,000 patients shows that simple, non-drug treatments like knee braces, hydrotherapy, and exercise can significantly ease knee osteoarthritis symptoms. These approaches not only reduce pain and improve mobility, but also avoid the risks tied to common medications. The findings suggest that low-cost, accessible therapies could play a bigger role in how doctors treat arthritis in the future. Mon, 30 Mar 2026 08:52:03 EDT https://www.sciencedaily.com/releases/2026/03/260330084511.htm https://www.sciencedaily.com/releases/2026/03/260328043558.htm Scientists have developed a new gene therapy that quiets pain at its source in the brain—without the addictive risks of opioids. Using AI to map how pain is processed, they created a targeted “off switch” that mimics morphine’s benefits but skips its dangerous side effects. In early tests, it delivered lasting relief without affecting normal sensations. The discovery could mark a major step toward safer, non-addictive pain treatments. Sat, 28 Mar 2026 20:57:04 EDT https://www.sciencedaily.com/releases/2026/03/260328043558.htm https://www.sciencedaily.com/releases/2026/03/260328043556.htm After a stroke, the brain may do something surprisingly hopeful—it can “refresh” parts of itself. Researchers analyzing brain scans from over 500 stroke survivors found that while the damaged side of the brain appears to age faster, the opposite, unaffected side can actually look younger. This unexpected shift seems to reflect the brain’s effort to rewire itself, strengthening healthy regions to compensate for lost function. Sun, 29 Mar 2026 06:34:17 EDT https://www.sciencedaily.com/releases/2026/03/260328043556.htm https://www.sciencedaily.com/releases/2026/03/260325005920.htm Researchers have identified a crucial ion channel, TMEM175, that acts like an overflow valve in the cell’s recycling system. It regulates acidity inside lysosomes, ensuring they function properly. When TMEM175 is faulty, toxic buildup can occur, contributing to diseases like Parkinson’s. This breakthrough reveals a promising new target for future therapies. Thu, 26 Mar 2026 07:35:07 EDT https://www.sciencedaily.com/releases/2026/03/260325005920.htm https://www.sciencedaily.com/releases/2026/03/260324230102.htm Balance problems in aging and Parkinson’s may come from the body working too hard, not too little. Scientists found that the brain and muscles become overactive during even minor disturbances, yet this actually weakens balance recovery. At the same time, muscles can stiffen against each other, making movement less stable. This unexpected pattern could help predict who is more likely to fall. Wed, 25 Mar 2026 00:29:12 EDT https://www.sciencedaily.com/releases/2026/03/260324230102.htm https://www.sciencedaily.com/releases/2026/03/260323005542.htm A new study suggests a widely used bone hormone could help relieve chronic back pain in an unexpected way. Instead of just strengthening bone, it appears to stop pain-sensing nerves from growing into damaged spinal areas. In animal models, this led to stronger spinal tissue and reduced pain sensitivity. The findings hint at a future treatment that tackles back pain at its biological roots. Mon, 23 Mar 2026 22:28:06 EDT https://www.sciencedaily.com/releases/2026/03/260323005542.htm https://www.sciencedaily.com/releases/2026/03/260323005526.htm Scientists have uncovered a hidden “death switch” in the brain that may be driving Alzheimer’s disease—and even found a way to turn it off in mice. The culprit is a toxic pairing of two proteins that, when combined, triggers the destruction of brain cells and fuels memory loss. By using a new compound to break apart this deadly duo, researchers were able to slow disease progression, protect brain cells, and even reduce hallmark amyloid buildup. Mon, 23 Mar 2026 05:34:10 EDT https://www.sciencedaily.com/releases/2026/03/260323005526.htm https://www.sciencedaily.com/releases/2026/03/260317064457.htm A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the Fc fragment. This piece acts like a trigger, prompting microglia to clear harmful amyloid plaques. The finding could reshape how future Alzheimer’s therapies are designed. Tue, 17 Mar 2026 07:44:52 EDT https://www.sciencedaily.com/releases/2026/03/260317064457.htm https://www.sciencedaily.com/releases/2026/03/260317064444.htm Early life stress may set the stage for long-term digestive problems by disrupting the gut-brain connection. Studies in both mice and thousands of children found links to symptoms like pain, constipation, and IBS. Scientists discovered that different biological pathways control different gut issues, hinting at more personalized treatments in the future. The research also highlights how a child’s early environment can have lasting physical effects—not just emotional ones. Tue, 17 Mar 2026 22:08:54 EDT https://www.sciencedaily.com/releases/2026/03/260317064444.htm https://www.sciencedaily.com/releases/2026/03/260315225156.htm A new clinical study suggests that successful root canal treatment may benefit more than just dental health. Patients treated for infected teeth showed improved blood sugar control, healthier cholesterol levels, and reduced inflammation over time. The infection can allow bacteria to enter the bloodstream, potentially affecting metabolism and heart health. Clearing the infection appears to help reverse some of these harmful effects. Sun, 15 Mar 2026 22:51:56 EDT https://www.sciencedaily.com/releases/2026/03/260315225156.htm https://www.sciencedaily.com/releases/2026/03/260315225125.htm A new UCLA Health study suggests that long-term exposure to the pesticide chlorpyrifos may dramatically raise the risk of Parkinson’s disease. Researchers found that people living in areas with sustained exposure had more than 2.5 times the likelihood of developing the disorder. Lab experiments reinforced the finding: animals exposed to the chemical developed movement problems, lost dopamine-producing neurons, and showed the same toxic protein buildup seen in Parkinson’s patients. Mon, 16 Mar 2026 18:49:45 EDT https://www.sciencedaily.com/releases/2026/03/260315225125.htm https://www.sciencedaily.com/releases/2026/03/260315004407.htm Melatonin is now widely used to help children sleep, but scientists say the enthusiasm may be getting ahead of the evidence. A major review found clear benefits for children with conditions like autism and ADHD, yet far less data exists for typical childhood insomnia. Researchers also warn about mislabeled supplement doses and rising accidental ingestions among young kids. Experts say melatonin should be used carefully and only alongside proven behavioral sleep strategies. Sun, 15 Mar 2026 07:08:26 EDT https://www.sciencedaily.com/releases/2026/03/260315004407.htm https://www.sciencedaily.com/releases/2026/03/260313002637.htm Tiny plastic particles may be quietly threatening brain health. New research suggests microplastics—now widely found in food, water, and even household dust—could trigger inflammation and damage in the brain through multiple biological pathways. Scientists estimate adults may consume about 250 grams of these particles each year, and some can accumulate in organs including the brain. Fri, 13 Mar 2026 20:38:26 EDT https://www.sciencedaily.com/releases/2026/03/260313002637.htm https://www.sciencedaily.com/releases/2026/03/260312020104.htm A new study suggests Alzheimer’s disease may be detectable through subtle shape changes in proteins found in the blood. Researchers discovered that structural differences in three blood proteins closely track the progression of the disease. By analyzing these changes in more than 500 people, the team was able to distinguish healthy individuals from those with mild cognitive impairment or Alzheimer’s with impressive accuracy. The approach could help move diagnosis and treatment to earlier stages. Thu, 12 Mar 2026 07:00:56 EDT https://www.sciencedaily.com/releases/2026/03/260312020104.htm https://www.sciencedaily.com/releases/2026/03/260311004720.htm Scientists have developed a promising new approach to treating Alzheimer’s disease by turning ordinary brain cells into powerful plaque-clearing machines. Instead of requiring frequent antibody infusions like current therapies, the experimental treatment uses genetically engineered astrocytes — abundant support cells in the brain — that are equipped with a CAR “homing device” similar to those used in cancer immunotherapy. Wed, 11 Mar 2026 17:01:42 EDT https://www.sciencedaily.com/releases/2026/03/260311004720.htm https://www.sciencedaily.com/releases/2026/03/260309225222.htm Colorblindness may be doing more than making traffic lights confusing — it could also be hiding a life-threatening warning sign. Researchers analyzing millions of medical records found that people with bladder cancer who are also colorblind have a 52% higher mortality rate over 20 years compared to those with normal vision. The likely reason: many people with color vision deficiency struggle to see red, making it harder to notice blood in urine, the most common early sign of bladder cancer. Tue, 10 Mar 2026 01:49:43 EDT https://www.sciencedaily.com/releases/2026/03/260309225222.htm https://www.sciencedaily.com/releases/2026/03/260309225154.htm A new analysis of more than 422,000 patients reveals a stark Alzheimer’s care gap between Maryland’s urban and rural communities. Rural regions often lack hospitals and dementia specialists, forcing older patients to travel farther for diagnosis and treatment. Researchers found areas with high Alzheimer’s death rates but surprisingly low diagnosis rates, suggesting many cases may never be identified. Mon, 09 Mar 2026 22:51:54 EDT https://www.sciencedaily.com/releases/2026/03/260309225154.htm https://www.sciencedaily.com/releases/2026/03/260307213244.htm A massive UK study of more than 165,000 dementia patients has uncovered troubling new evidence about risperidone, a commonly used drug for severe agitation. Researchers found the antipsychotic increases stroke risk in dementia patients across the board—including those with no prior heart disease or stroke—challenging the long-held belief that some patients might be safer candidates than others. Because risperidone is the only drug of its type licensed for dementia, doctors often use it as a last resort when distressing symptoms become unmanageable. Sun, 08 Mar 2026 16:45:01 EDT https://www.sciencedaily.com/releases/2026/03/260307213244.htm https://www.sciencedaily.com/releases/2026/03/260307155945.htm Scientists have uncovered a surprising new role for little-known brain cells called tanycytes that may influence the development of Alzheimer’s disease. These specialized cells appear to help remove toxic tau protein from the brain by transporting it from the cerebrospinal fluid into the bloodstream. When tanycytes become damaged or dysfunctional, tau can accumulate in the brain, a hallmark of Alzheimer’s. Sun, 08 Mar 2026 06:14:34 EDT https://www.sciencedaily.com/releases/2026/03/260307155945.htm https://www.sciencedaily.com/releases/2026/03/260303145730.htm A new study has uncovered why some brain cells are more resistant to Alzheimer’s damage than others. Researchers found a natural cleanup system that helps remove toxic tau protein before it can form harmful clumps. The study also shows that cellular stress can produce a dangerous tau fragment linked to Alzheimer’s. Strengthening the brain’s natural defenses could point the way to new treatments. Tue, 03 Mar 2026 21:38:45 EST https://www.sciencedaily.com/releases/2026/03/260303145730.htm https://www.sciencedaily.com/releases/2026/02/260228093505.htm Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining laser-based imaging with machine learning, they uncovered chemical changes that spread unevenly across the brain and extend beyond amyloid plaques. Key memory regions showed major shifts in cholesterol and energy-related molecules. The findings hint that Alzheimer’s is a whole-brain metabolic disruption—not just a protein problem. Sun, 01 Mar 2026 10:16:01 EST https://www.sciencedaily.com/releases/2026/02/260228093505.htm https://www.sciencedaily.com/releases/2026/02/260227061818.htm Heart disease is on track to tighten its grip on American women. New projections from the American Heart Association warn that over the next 25 years, cardiovascular disease will rise sharply, driven largely by a surge in high blood pressure, diabetes, and obesity. By 2050, nearly 60% of women in the U.S. could have high blood pressure, and close to one in three women ages 22 to 44 may already be living with some form of heart disease. Fri, 27 Feb 2026 06:18:18 EST https://www.sciencedaily.com/releases/2026/02/260227061818.htm https://www.sciencedaily.com/releases/2026/02/260225081208.htm A sweeping new analysis of the evidence suggests that exercise therapy — long promoted as a first-line treatment for osteoarthritis — may offer only small and short-lived relief, and in some cases might be no better than doing nothing at all. After reviewing dozens of clinical trials involving more than 13,000 participants, researchers found that benefits for knee osteoarthritis pain were minimal and tended to shrink in larger or longer-term studies. Wed, 25 Feb 2026 23:43:58 EST https://www.sciencedaily.com/releases/2026/02/260225081208.htm https://www.sciencedaily.com/releases/2026/02/260224023159.htm Subtle changes in brain blood flow and oxygen use are closely linked to hallmark signs of Alzheimer’s, including amyloid plaques and memory-related brain shrinkage. Simple, noninvasive scans may one day help spot risk earlier—by looking at the brain’s vascular health, not just its plaques. Tue, 24 Feb 2026 10:21:58 EST https://www.sciencedaily.com/releases/2026/02/260224023159.htm https://www.sciencedaily.com/releases/2026/02/260222085203.htm Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to four years. The protein mirrors the silent buildup of amyloid and tau in the brain long before memory loss appears. This advance could speed up preventive drug trials and eventually guide personalized care. Mon, 23 Feb 2026 06:46:07 EST https://www.sciencedaily.com/releases/2026/02/260222085203.htm https://www.sciencedaily.com/releases/2026/02/260221000321.htm A common bacterium best known for causing pneumonia and sinus infections may also play a surprising role in Alzheimer’s disease. Researchers found that Chlamydia pneumoniae can invade the retina and brain, where it sparks inflammation, nerve cell death, and the buildup of amyloid-beta—the hallmark protein linked to Alzheimer’s. Higher levels of the bacterium were found in people with Alzheimer’s, especially those carrying the high-risk APOE4 gene, and were tied to more severe cognitive decline. Sat, 21 Feb 2026 00:43:23 EST https://www.sciencedaily.com/releases/2026/02/260221000321.htm https://www.sciencedaily.com/releases/2026/02/260221000255.htm Chronic wounds often spiral out of control because oxygen can’t reach the deepest layers of injured tissue. A new gel developed at UC Riverside delivers a continuous flow of oxygen right where it’s needed most, using a tiny battery-powered system. In high-risk mice, wounds healed in weeks instead of worsening. The innovation could dramatically reduce amputations—and may even open doors for lab-grown organs. Sun, 22 Feb 2026 08:14:18 EST https://www.sciencedaily.com/releases/2026/02/260221000255.htm https://www.sciencedaily.com/releases/2026/02/260220010836.htm Breathing polluted air may do more than harm your lungs — it could also increase your risk of Alzheimer’s disease. In a sweeping study of nearly 28 million older Americans, researchers found that long term exposure to fine particle air pollution was linked to a higher likelihood of developing Alzheimer’s. The connection appeared to stem largely from pollution’s direct effects on the brain, rather than through related health conditions like hypertension or depression. Fri, 20 Feb 2026 01:47:05 EST https://www.sciencedaily.com/releases/2026/02/260220010836.htm https://www.sciencedaily.com/releases/2026/02/260219040820.htm A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is driven by the gradual loss of dopamine-producing cells—leading to tremors, stiffness, and slowed movement—researchers are implanting lab-grown cells directly into the brain’s movement center to replace what’s been lost. Fri, 20 Feb 2026 04:03:58 EST https://www.sciencedaily.com/releases/2026/02/260219040820.htm https://www.sciencedaily.com/releases/2026/02/260219040816.htm A new human study has uncovered how the body naturally turns off inflammation. Researchers found that fat-derived molecules called epoxy-oxylipins rein in immune cells that can otherwise drive chronic disease. Using a drug to boost these molecules reduced pain faster and lowered harmful inflammatory cells. The discovery could pave the way for safer treatments for arthritis, heart disease, and other inflammation-related conditions. Thu, 19 Feb 2026 10:16:55 EST https://www.sciencedaily.com/releases/2026/02/260219040816.htm https://www.sciencedaily.com/releases/2026/02/260219040752.htm Exercise may sharpen the mind by repairing the brain’s protective shield. Researchers found that physical activity prompts the liver to release an enzyme that removes a harmful protein causing the blood-brain barrier to become leaky with age. In older mice, dialing down this protein reduced inflammation and improved memory. The discovery points to a surprising body-to-brain pathway that could inspire new Alzheimer’s therapies. Fri, 20 Feb 2026 10:19:43 EST https://www.sciencedaily.com/releases/2026/02/260219040752.htm https://www.sciencedaily.com/releases/2026/02/260219040745.htm A newly discovered bacterial duo may be the hidden cause of chronic constipation. The two microbes break down the colon’s protective mucus layer, leaving stool dry and hard — a problem traditional laxatives don’t fix. Parkinson’s patients, who often struggle with constipation years before tremors appear, have higher levels of these bacteria. Blocking the bacteria’s mucus-destroying enzyme prevented constipation in mice, hinting at a new treatment strategy. Thu, 19 Feb 2026 08:46:05 EST https://www.sciencedaily.com/releases/2026/02/260219040745.htm https://www.sciencedaily.com/releases/2026/02/260217005759.htm A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimer’s disease — with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing. Wed, 18 Feb 2026 07:02:28 EST https://www.sciencedaily.com/releases/2026/02/260217005759.htm https://www.sciencedaily.com/releases/2026/02/260215225555.htm Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s disease. By stimulating these receptors in mice, scientists increased levels of a natural amyloid-breaking enzyme, reduced buildup in the brain, and improved memory-related behavior. Because these receptors are common drug targets, the findings could open the door to affordable pill-based treatments with fewer side effects. Tue, 17 Feb 2026 05:30:08 EST https://www.sciencedaily.com/releases/2026/02/260215225555.htm https://www.sciencedaily.com/releases/2026/02/260215084954.htm Scientists have created the most detailed maps yet of how genes control one another inside the brains of people with Alzheimer’s disease. Using a powerful new AI-based system called SIGNET, the team uncovered cause-and-effect relationships between genes across six major brain cell types, revealing which genes are truly driving harmful changes. The most dramatic disruptions were found in excitatory neurons, where thousands of genetic interactions appear to be extensively rewired as the disease progresses. Sun, 15 Feb 2026 09:15:19 EST https://www.sciencedaily.com/releases/2026/02/260215084954.htm https://www.sciencedaily.com/releases/2026/02/260212234218.htm Scientists at Cedars-Sinai have uncovered a surprising repair system in the spinal cord that could open new doors for treating paralysis, stroke, and diseases like multiple sclerosis. They found that special support cells called astrocytes—located far from the actual injury—spring into action after damage. These “lesion-remote astrocytes” send out a protein signal, CCN1, that reprograms immune cells to efficiently clean up fatty nerve debris. Fri, 13 Feb 2026 08:47:43 EST https://www.sciencedaily.com/releases/2026/02/260212234218.htm https://www.sciencedaily.com/releases/2026/02/260211073023.htm A simple brain-training program that sharpens how quickly older adults process visual information may have a surprisingly powerful long-term payoff. In a major 20-year study of adults 65 and older, those who completed five to six weeks of adaptive “speed of processing” training — along with a few booster sessions — were significantly less likely to develop dementia, including Alzheimer’s disease, even two decades later. Participants who received the boosted speed training had a 25% lower dementia risk compared to those who received no training, making it the only intervention in the trial to show such a lasting protective effect. Wed, 11 Feb 2026 22:15:24 EST https://www.sciencedaily.com/releases/2026/02/260211073023.htm https://www.sciencedaily.com/releases/2026/02/260210040623.htm Depression in older adults may sometimes signal the early stages of Parkinson’s disease or Lewy body dementia. Researchers found that depression often appears years before diagnosis and remains elevated long afterward, unlike in other chronic illnesses. This suggests depression may reflect early brain changes rather than emotional distress alone. Wed, 11 Feb 2026 06:57:31 EST https://www.sciencedaily.com/releases/2026/02/260210040623.htm https://www.sciencedaily.com/releases/2026/02/260209064310.htm A long-term study found that women who closely followed a Mediterranean diet had a much lower risk of stroke. The strongest benefits were seen in women who ate more plant-based foods, fish, and olive oil while cutting back on red meat and saturated fats. Their risk dropped across all major stroke types, including bleeding strokes, which are less commonly studied. The findings suggest diet may be a powerful but overlooked factor in stroke prevention. Mon, 09 Feb 2026 06:54:46 EST https://www.sciencedaily.com/releases/2026/02/260209064310.htm https://www.sciencedaily.com/releases/2026/02/260208203013.htm A new international study points to a specific brain network as the core driver of Parkinson’s disease. Scientists found that this network becomes overly connected, disrupting not just movement but also thinking and other bodily functions. When researchers targeted it with non-invasive brain stimulation, patients showed much stronger symptom improvement than with conventional stimulation. The discovery could reshape how Parkinson’s is diagnosed and treated. Sun, 08 Feb 2026 20:37:23 EST https://www.sciencedaily.com/releases/2026/02/260208203013.htm https://www.sciencedaily.com/releases/2026/02/260206012213.htm Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease. Using advanced computer modeling, researchers discovered that beta-sitosterol—a natural plant compound—strongly interacts with two key enzymes involved in memory loss and cognitive decline. The compound showed stability, strong binding, and favorable safety indicators, making it a standout candidate for future drug development. Sun, 08 Feb 2026 07:57:41 EST https://www.sciencedaily.com/releases/2026/02/260206012213.htm https://www.sciencedaily.com/releases/2026/02/260206012203.htm Scientists at Keck Medicine of USC are testing an experimental stem cell therapy that aims to restore the brain’s ability to produce dopamine, the chemical whose loss drives Parkinson’s disease. The early-stage clinical trial involves implanting lab-grown dopamine-producing cells directly into a key movement-control region of the brain, with the hope of slowing disease progression and improving motor function. Fri, 06 Feb 2026 06:57:35 EST https://www.sciencedaily.com/releases/2026/02/260206012203.htm https://www.sciencedaily.com/releases/2026/02/260203030529.htm Sound machines may not be the sleep saviors many believe. Researchers found that pink noise significantly reduced REM sleep, while simple earplugs did a better job protecting deep, restorative sleep from traffic noise. When pink noise was combined with outside noise, sleep quality dropped even further. The results suggest that popular “sleep sounds” could be doing more harm than good—particularly for kids. Wed, 04 Feb 2026 00:58:14 EST https://www.sciencedaily.com/releases/2026/02/260203030529.htm https://www.sciencedaily.com/releases/2026/02/260201223732.htm Researchers studying nearly 2 million older adults found that cerebral amyloid angiopathy sharply raises the risk of developing dementia. Within five years, people with the condition were far more likely to be diagnosed than those without it. The increased risk was present even without a history of stroke. Experts say this makes early screening for memory and thinking changes especially important. Sun, 01 Feb 2026 23:08:47 EST https://www.sciencedaily.com/releases/2026/02/260201223732.htm https://www.sciencedaily.com/releases/2026/02/260201062459.htm When the brain rests, it usually replays recent experiences to strengthen memory. Scientists found that in Alzheimer’s-like mice, this replay still occurs — but the signals are jumbled and poorly coordinated. As a result, memory-supporting brain cells lose their stability, and the animals struggle to remember where they’ve been. Sun, 01 Feb 2026 10:41:29 EST https://www.sciencedaily.com/releases/2026/02/260201062459.htm https://www.sciencedaily.com/releases/2026/02/260201062457.htm Middle age is becoming a tougher chapter for many Americans, especially those born in the 1960s and early 1970s. Compared with earlier generations, they report more loneliness and depression, along with weaker physical strength and declining memory. These troubling trends stand out internationally, as similar declines are largely absent in other wealthy nations, particularly in Nordic Europe, where midlife well-being has improved. Sun, 01 Feb 2026 10:25:53 EST https://www.sciencedaily.com/releases/2026/02/260201062457.htm https://www.sciencedaily.com/releases/2026/01/260131082433.htm Lowering salt in everyday foods could quietly save lives. Researchers found that modest sodium reductions in bread, packaged foods, and takeout meals could significantly reduce heart disease and stroke rates in France and the U.K. The key advantage is that people would not need to alter their eating habits at all. Small changes to the food supply could deliver large, long-term health benefits. Sat, 31 Jan 2026 09:27:42 EST https://www.sciencedaily.com/releases/2026/01/260131082433.htm https://www.sciencedaily.com/releases/2026/01/260129080424.htm Scientists in Sweden and Norway have uncovered a promising way to spot Parkinson’s disease years—possibly decades—before its most damaging symptoms appear. By detecting subtle biological signals in the blood tied to how cells handle stress and repair DNA, the team identified a brief early window when Parkinson’s quietly leaves a measurable fingerprint. Thu, 29 Jan 2026 09:26:14 EST https://www.sciencedaily.com/releases/2026/01/260129080424.htm https://www.sciencedaily.com/releases/2026/01/260128230518.htm Helping care for grandchildren may offer an unexpected boost to brain health later in life. Researchers found that grandparents who provided childcare scored higher on memory and verbal skills than those who did not. The effect did not depend on how often they helped or the type of care they provided. Being involved as a caregiver itself appeared to matter most. Thu, 29 Jan 2026 03:06:44 EST https://www.sciencedaily.com/releases/2026/01/260128230518.htm https://www.sciencedaily.com/releases/2026/01/260125083413.htm Alzheimer’s may destroy memory by flipping a single molecular switch that tells neurons to prune their own connections. Researchers found that both amyloid beta and inflammation converge on the same receptor, triggering synapse loss. Surprisingly, neurons aren’t passive victims—they actively respond to these signals. Targeting this receptor could offer a new way to protect memory beyond current amyloid-focused drugs. Mon, 26 Jan 2026 03:08:27 EST https://www.sciencedaily.com/releases/2026/01/260125083413.htm